Investments
6Portfolio Exits
3About Monashee Capital
Monashee Capital Corp. is a corporate finance and advisory firm that has a focus primarily toward private companies. Monashee advises business owners regarding corporate strategy; succession planning; Board governance; mergers, acquisitions and divestitures; and the raising of capital to support growth or other initiatives. Pacific Southshore Ventures Inc. (PSVI) is an affiliated private investment firm with a mandate to make investments in established businesses involved in the industrial, distribution, packaging, service, branded consumer product and manufacturing sectors. PSVI has the ability to be flexible regarding the type and form of investment structure and strives to be a preferred financing partner and trusted advisor.
Monashee Capital Headquarter Location
2497 Marine Drive
West Vancouver, British Columbia, V7V 1L3,
Canada
778-340-4011
Latest Monashee Capital News
Jul 20, 2022
SOURCE Global, PBC ('SOURCE'), a world leader in sustainable drinking water technology, today announced that funds managed by Breakthrough Energy Ventures and Drawdown Fund co-led its $130 million Series D equity financing. Other significant participants in the financing are Microsoft's Climate Innovation Fund, Fifth Wall, Blackrock, WIND Ventures, Duke Energy, Harvard Management Company, Material Impact Partners, Monashee Capital, and the Lightsmith Group. Source Global, PBC's mission is to perfect drinking water for every person, every place. The company's SOURCE® Hydropanels create drinking water using sunlight and air as the only inputs, and can put the power of safe, sustainable drinking water in the hands of every person in nearly every climate and corner of the world. A Public Benefit Corporation, SOURCE is on Fast Company's 2020 list of most innovative social good companies. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Monashee Capital Investments
6 Investments
Monashee Capital has made 6 investments. Their latest investment was in Structure Therapeutics as part of their Series B on August 8, 2021.
Monashee Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/2/2021 | Series B | Structure Therapeutics | $100M | Yes | 7 | |
6/24/2021 | Series D | |||||
1/28/2015 | Series C - II | |||||
4/16/2014 | PIPE | |||||
3/11/2014 | Series B |
Date | 8/2/2021 | 6/24/2021 | 1/28/2015 | 4/16/2014 | 3/11/2014 |
|---|---|---|---|---|---|
Round | Series B | Series D | Series C - II | PIPE | Series B |
Company | Structure Therapeutics | ||||
Amount | $100M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 7 |
Monashee Capital Portfolio Exits
3 Portfolio Exits
Monashee Capital has 3 portfolio exits. Their latest portfolio exit was BioNano Genomics on August 21, 2018.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/21/2018 | IPO | Public | 2 | ||
Date | 8/21/2018 | ||
|---|---|---|---|
Exit | IPO | ||
Companies | |||
Valuation | |||
Acquirer | Public | ||
Sources | 2 |
Monashee Capital Team
1 Team Member
Monashee Capital has 1 team member, including current President, Kevin Budd.
Name | Work History | Title | Status |
|---|---|---|---|
Kevin Budd | Methanex | President | Current |
Name | Kevin Budd |
|---|---|
Work History | Methanex |
Title | President |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.